TY - JOUR AU - Samii, A. AU - Nutt, J. G. AU - Ransom, B. PY - 2004 DA - 2004// TI - Parkinson's disease JO - Lancet VL - 363 UR - https://doi.org/10.1016/S0140-6736(04)16305-8 DO - 10.1016/S0140-6736(04)16305-8 ID - Samii2004 ER - TY - JOUR AU - Bernheimer, H. AU - Birkmayer, W. AU - Hornykiewicz, O. AU - Jellinger, K. AU - Seitelberger, F. PY - 1973 DA - 1973// TI - Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations JO - J Neurol Sci VL - 20 UR - https://doi.org/10.1016/0022-510X(73)90175-5 DO - 10.1016/0022-510X(73)90175-5 ID - Bernheimer1973 ER - TY - JOUR AU - Agid, Y. PY - 1991 DA - 1991// TI - Parkinson’s disease: pathophysiology JO - Lancet VL - 337 UR - https://doi.org/10.1016/0140-6736(91)92989-F DO - 10.1016/0140-6736(91)92989-F ID - Agid1991 ER - TY - JOUR AU - Miyasaki, J. M. AU - Martin, W. AU - Suchowersky, O. AU - Weiner, W. J. AU - Lang, A. E. PY - 2002 DA - 2002// TI - Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology JO - J Neurol VL - 58 UR - https://doi.org/10.1212/WNL.58.1.11 DO - 10.1212/WNL.58.1.11 ID - Miyasaki2002 ER - TY - JOUR AU - Jain, L. AU - Benko, R. AU - Safranek, S. PY - 2012 DA - 2012// TI - Clinical inquiry. Which drugs work best for early Parkinson's disease? JO - J Fam Pract VL - 61 ID - Jain2012 ER - TY - JOUR AU - Rascol, O. AU - Fabre, N. PY - 2001 DA - 2001// TI - Dyskinesia: ʟ-dopa-induced and tardive dyskinesia JO - Clin Neuropharmacol VL - 24 UR - https://doi.org/10.1097/00002826-200111000-00002 DO - 10.1097/00002826-200111000-00002 ID - Rascol2001 ER - TY - JOUR AU - Mathur, B. N. AU - Lovinger, D. M. PY - 2012 DA - 2012// TI - Serotonergic action on dorsal striatal function JO - Parkinsonism Relat Disord VL - 18 UR - https://doi.org/10.1016/S1353-8020(11)70040-2 DO - 10.1016/S1353-8020(11)70040-2 ID - Mathur2012 ER - TY - JOUR AU - Cheshire, P. A. AU - Williams, D. R. PY - 2012 DA - 2012// TI - Serotonergic involvement in levodopa-induced dyskinesias in Parkinson's disease JO - J Clin Neurosci VL - 19 UR - https://doi.org/10.1016/j.jocn.2011.09.008 DO - 10.1016/j.jocn.2011.09.008 ID - Cheshire2012 ER - TY - JOUR AU - Prinssen, E. P. AU - Colpaert, F. C. AU - Koek, W. PY - 2002 DA - 2002// TI - 5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy JO - Eur J Pharmacol VL - 453 UR - https://doi.org/10.1016/S0014-2999(02)02430-5 DO - 10.1016/S0014-2999(02)02430-5 ID - Prinssen2002 ER - TY - JOUR AU - Neal-Beliveau, B. S. AU - Joyce, J. N. AU - Lucki, I. PY - 2003 DA - 2003// TI - Serotonergic involvement in haloperidol-induced catalepsy JO - J Pharmacol Exp Ther VL - 265 ID - Neal-Beliveau2003 ER - TY - JOUR AU - Ohno, Y. PY - 2011 DA - 2011// TI - Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease JO - CNS Neurosci Ther VL - 17 UR - https://doi.org/10.1111/j.1755-5949.2010.00211.x DO - 10.1111/j.1755-5949.2010.00211.x ID - Ohno2011 ER - TY - JOUR AU - Holm, K. J. AU - Markham, A. PY - 1999 DA - 1999// TI - Mirtazapine: a review of its use in major depression JO - Drugs VL - 57 UR - https://doi.org/10.2165/00003495-199957040-00010 DO - 10.2165/00003495-199957040-00010 ID - Holm1999 ER - TY - JOUR AU - De Boer, T. PY - 1996 DA - 1996// TI - The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission JO - Int Clin Psychopharmacol VL - 10 ID - De Boer1996 ER - TY - JOUR AU - De Boer, T. PY - 1996 DA - 1996// TI - The pharmacologic profile of mirtazapine JO - J Clin Psychiatry VL - 57 ID - De Boer1996 ER - TY - JOUR AU - Bremner, J. D. PY - 1995 DA - 1995// TI - A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression JO - J Clin Psychiatry VL - 56 ID - Bremner1995 ER - TY - JOUR AU - van Moffaert, M. AU - de Wilde, J. AU - Vereecken, A. AU - Dierick, M. AU - Evrard, J. L. AU - Wilmotte, J. AU - Mendlewicz, J. PY - 1995 DA - 1995// TI - Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression JO - Int Clin Psychopharmacol VL - 10 UR - https://doi.org/10.1097/00004850-199503000-00001 DO - 10.1097/00004850-199503000-00001 ID - van Moffaert1995 ER - TY - JOUR AU - Fawcett, J. AU - Barkin, R. L. PY - 1998 DA - 1998// TI - Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression JO - J Affect Disord VL - 51 UR - https://doi.org/10.1016/S0165-0327(98)00224-9 DO - 10.1016/S0165-0327(98)00224-9 ID - Fawcett1998 ER - TY - JOUR AU - Amini, H. AU - Aghayan, S. AU - Jalili, S. A. AU - Akhondzadeh, S. AU - Yahyazadeh, O. AU - Pakravan-Nejad, M. PY - 2005 DA - 2005// TI - Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial JO - J Clin Pharm Ther VL - 30 UR - https://doi.org/10.1111/j.1365-2710.2004.00585.x DO - 10.1111/j.1365-2710.2004.00585.x ID - Amini2005 ER - TY - JOUR AU - Høyberg, O. J. AU - Maragakis, B. AU - Mullin, J. AU - Norum, D. AU - Stordall, E. AU - Ekdahl, P. AU - Ose, E. AU - Moksnes, K. M. AU - Sennef, C. PY - 1996 DA - 1996// TI - A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients JO - Acta Psychiatr Scand VL - 93 UR - https://doi.org/10.1111/j.1600-0447.1996.tb10629.x DO - 10.1111/j.1600-0447.1996.tb10629.x ID - Høyberg1996 ER - TY - JOUR AU - Nakayama, K. AU - Sakurai, T. AU - Katsu, H. PY - 2004 DA - 2004// TI - Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation JO - Brain Res Bull VL - 63 UR - https://doi.org/10.1016/j.brainresbull.2004.02.007 DO - 10.1016/j.brainresbull.2004.02.007 ID - Nakayama2004 ER - TY - JOUR AU - Gordon, P. H. AU - Pullman, S. L. AU - Louis, E. D. AU - Frucht, S. J. AU - Fahn, S. PY - 2002 DA - 2002// TI - Mirtazapine in Parkinsonian tremor JO - Parkinsonism Relat Disord VL - 9 UR - https://doi.org/10.1016/S1353-8020(02)00011-1 DO - 10.1016/S1353-8020(02)00011-1 ID - Gordon2002 ER - TY - JOUR AU - Fox, S. H. PY - 2013 DA - 2013// TI - Non-dopaminergic treatments for motor control in Parkinson's disease JO - Drugs VL - 73 UR - https://doi.org/10.1007/s40265-013-0105-4 DO - 10.1007/s40265-013-0105-4 ID - Fox2013 ER - TY - CHAP AU - Kasahara, J. AU - Choudhury, M. E. AU - Yokoyama, H. AU - Kadoguchi, N. AU - Nomoto, M. ED - Conn, P. M. PY - 2013 DA - 2013// TI - Neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced animal models for Parkinson's disease BT - Animal Models for The Study of Human Disease PB - Academic Press CY - London UR - https://doi.org/10.1016/B978-0-12-415894-8.00026-9 DO - 10.1016/B978-0-12-415894-8.00026-9 ID - Kasahara2013 ER - TY - JOUR AU - Yokoyama, H. AU - Kuroiwa, H. AU - Kasahara, J. AU - Araki, T. PY - 2011 DA - 2011// TI - Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced mouse model of Parkinson's disease JO - Acta Neurobiol Exp VL - 71 ID - Yokoyama2011 ER - TY - JOUR AU - Yokoyama, H. AU - Yano, R. AU - Kuroiwa, H. AU - Tsukada, T. AU - Uchida, H. AU - Kato, H. AU - Kasahara, J. AU - Araki, T. PY - 2010 DA - 2010// TI - Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice JO - Metab Brain Dis VL - 25 UR - https://doi.org/10.1007/s11011-010-9191-0 DO - 10.1007/s11011-010-9191-0 ID - Yokoyama2010 ER - TY - JOUR AU - Yabe, H. AU - Choudhury, M. E. AU - Kubo, M. AU - Nishikawa, N. AU - Nagai, M. AU - Nomoto, M. PY - 2009 DA - 2009// TI - Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP JO - J Pharmacol Sci VL - 110 UR - https://doi.org/10.1254/jphs.09019FP DO - 10.1254/jphs.09019FP ID - Yabe2009 ER - TY - JOUR AU - Grenhoff, J. AU - Svensson, T. H. PY - 1993 DA - 1993// TI - Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area JO - Eur J Pharmacol VL - 233 UR - https://doi.org/10.1016/0014-2999(93)90351-H DO - 10.1016/0014-2999(93)90351-H ID - Grenhoff1993 ER - TY - JOUR AU - Kapur, S. AU - Remington, G. PY - 1996 DA - 1996// TI - Serotonin-dopamine interaction and its relevance to schizophrenia JO - Am J Psychiatry VL - 153 UR - https://doi.org/10.1176/ajp.153.4.466 DO - 10.1176/ajp.153.4.466 ID - Kapur1996 ER - TY - JOUR AU - Blier, P. PY - 2001 DA - 2001// TI - Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response JO - J Psychiatry Neurosci VL - 26 ID - Blier2001 ER - TY - JOUR AU - Blandini, F. AU - Armentero, M. T. PY - 2012 DA - 2012// TI - Animal models of Parkinson's disease JO - FEBS J VL - 279 UR - https://doi.org/10.1111/j.1742-4658.2012.08491.x DO - 10.1111/j.1742-4658.2012.08491.x ID - Blandini2012 ER - TY - JOUR AU - Rose, S. AU - Nomoto, M. AU - Kelly, E. AU - Kilpatrick, G. AU - Jenner, P. AU - Marsden, C. D. PY - 1989 DA - 1989// TI - Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP JO - Neurosci Lett VL - 101 UR - https://doi.org/10.1016/0304-3940(89)90550-8 DO - 10.1016/0304-3940(89)90550-8 ID - Rose1989 ER - TY - JOUR AU - Gainetdinov, R. R. AU - Caron, M. G. PY - 2003 DA - 2003// TI - Monoamine transporters: from genes to behavior JO - Annu Rev Pharmacol Toxicol VL - 43 UR - https://doi.org/10.1146/annurev.pharmtox.43.050802.112309 DO - 10.1146/annurev.pharmtox.43.050802.112309 ID - Gainetdinov2003 ER - TY - JOUR AU - Leviel, V. PY - 2011 DA - 2011// TI - Dopamine release mediated by the dopamine transporter, facts and consequences JO - J Neurochem VL - 118 UR - https://doi.org/10.1111/j.1471-4159.2011.07335.x DO - 10.1111/j.1471-4159.2011.07335.x ID - Leviel2011 ER - TY - JOUR AU - Dazzi, L. AU - Spiga, F. AU - Pira, L. AU - Ladu, S. AU - Vacca, G. AU - Rivano, A. AU - Jentsch, J. D. AU - Biggio, G. PY - 2001 DA - 2001// TI - Inhibition of stress- or anxiogenic-drug-induced increases in dopamine release in the rat prefrontal cortex by long-term treatment with antidepressant drugs JO - J Neurochem VL - 76 UR - https://doi.org/10.1046/j.1471-4159.2001.00148.x DO - 10.1046/j.1471-4159.2001.00148.x ID - Dazzi2001 ER - TY - JOUR AU - Anttila, S. A. AU - Leinonen, E. V. PY - 2001 DA - 2001// TI - A review of the pharmacological and clinical profile of mirtazapine JO - CNS Drug Rev VL - 7 UR - https://doi.org/10.1111/j.1527-3458.2001.tb00198.x DO - 10.1111/j.1527-3458.2001.tb00198.x ID - Anttila2001 ER - TY - JOUR AU - Di Giovanni, G. AU - Esposito, E. AU - Di Matteo, V. PY - 2010 DA - 2010// TI - Role of serotonin in central dopamine dysfunction JO - CNS Neurosci Ther VL - 16 UR - https://doi.org/10.1111/j.1755-5949.2010.00135.x DO - 10.1111/j.1755-5949.2010.00135.x ID - Di Giovanni2010 ER - TY - JOUR AU - Sharp, T. AU - Boothman, L. AU - Raley, J. AU - Quérée, P. PY - 2007 DA - 2007// TI - Important messages in the 'post': recent discoveries in 5-HT neurone feedback control JO - Trends Pharmacol Sci VL - 28 UR - https://doi.org/10.1016/j.tips.2007.10.009 DO - 10.1016/j.tips.2007.10.009 ID - Sharp2007 ER - TY - JOUR AU - Ferguson, M. C. AU - Nayyar, T. AU - Deutch, A. Y. AU - Ansah, T. A. PY - 2010 DA - 2010// TI - 5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease JO - Neuropharmacology VL - 59 UR - https://doi.org/10.1016/j.neuropharm.2010.03.013 DO - 10.1016/j.neuropharm.2010.03.013 ID - Ferguson2010 ER - TY - JOUR AU - Mignon, L. AU - Wolf, W. A. PY - 2002 DA - 2002// TI - Postsynaptic 5-HT1A receptors mediate an increase in locomotor activity in the monoamine-depleted rat JO - Psychopharmacology VL - 163 UR - https://doi.org/10.1007/s00213-002-1121-3 DO - 10.1007/s00213-002-1121-3 ID - Mignon2002 ER - TY - JOUR AU - Ishibashi, T. AU - Ohno, Y. PY - 2004 DA - 2004// TI - Antiparkinsonian actions of a selective 5-HT1A agonist, tandospirone, in rats JO - Biog Amines VL - 8 UR - https://doi.org/10.1163/1569391041501924 DO - 10.1163/1569391041501924 ID - Ishibashi2004 ER - TY - JOUR AU - Dupre, K. B. AU - Eskow, K. L. AU - Barnum, C. J. AU - Bishop, C. PY - 2008 DA - 2008// TI - Striatal 5-HT1A receptor stimulation reduces D1 receptor-induce dyskinesia and improves movement in the hemiparkinsonian rat JO - Neuropharmacology VL - 55 UR - https://doi.org/10.1016/j.neuropharm.2008.08.031 DO - 10.1016/j.neuropharm.2008.08.031 ID - Dupre2008 ER - TY - JOUR AU - Shimizu, S. AU - Tatara, A. AU - Imaki, J. AU - Ohno, Y. PY - 2010 DA - 2010// TI - Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders JO - Prog Neuro-Psychopharmacol Biol Psychiat VL - 34 UR - https://doi.org/10.1016/j.pnpbp.2010.04.005 DO - 10.1016/j.pnpbp.2010.04.005 ID - Shimizu2010 ER - TY - JOUR AU - El Mansari, M. AU - Guiard, B. P. AU - Chernoloz, O. AU - Ghanbari, R. AU - Katz, N. AU - Blier, P. PY - 2010 DA - 2010// TI - Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder JO - CNS Neurosci Ther VL - 16 UR - https://doi.org/10.1111/j.1755-5949.2010.00146.x DO - 10.1111/j.1755-5949.2010.00146.x ID - El Mansari2010 ER - TY - JOUR AU - Ogawa, N. AU - Asanuma, M. AU - Miyazaki, I. AU - Diaz-Corrales, F. AU - Miyoshi, K. PY - 2005 DA - 2005// TI - ʟ-DOPA treatment from the viewpoint of neuroprotection: Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson’s disease JO - J Neurol VL - 252 ID - Ogawa2005 ER - TY - JOUR AU - Ahlskog, J. E. AU - Munenter, M. D. PY - 2001 DA - 2001// TI - Frequency of levodoparelated dyskinesias and motor fluctuations as estimated from the cumulative literature JO - Mov Disord VL - 16 UR - https://doi.org/10.1002/mds.1090 DO - 10.1002/mds.1090 ID - Ahlskog2001 ER - TY - JOUR AU - Inden, M. AU - Abe, M. AU - Minamino, H. AU - Takata, K. AU - Yoshimoto, K. AU - Tooyama, I. AU - Kitamura, Y. PY - 2012 DA - 2012// TI - Effect of selective serotonin reuptake inhibitors via 5-HT1A receptors on ʟ-DOPA-induced rotational behavior in a hemiparkinsonian rat model JO - J Pharmacol Sci VL - 119 UR - https://doi.org/10.1254/jphs.12003FP DO - 10.1254/jphs.12003FP ID - Inden2012 ER - TY - JOUR AU - Johnston, T. H. AU - Fox, S. H. AU - Piggott, M. J. AU - Savola, J. M. AU - Brotchie, J. M. PY - 2012 DA - 2012// TI - The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates JO - Mov Disord VL - 25 UR - https://doi.org/10.1002/mds.23172 DO - 10.1002/mds.23172 ID - Johnston2012 ER - TY - JOUR AU - Costa, F. H. AU - Rosso, A. L. AU - Maultasch, H. AU - Nicaretta, D. H. AU - Vincent, M. B. PY - 2012 DA - 2012// TI - Depression in Parkinson's disease: diagnosis and treatment JO - Arq Neuropsiquiatr VL - 70 UR - https://doi.org/10.1590/S0004-282X2012000800011 DO - 10.1590/S0004-282X2012000800011 ID - Costa2012 ER - TY - JOUR AU - Perez-Lloret, S. AU - Rascol, O. PY - 2012 DA - 2012// TI - Parkinson disease: Serotonin reuptake inhibitors for depression in PD JO - Nat Rev Neurol VL - 8 UR - https://doi.org/10.1038/nrneurol.2012.111 DO - 10.1038/nrneurol.2012.111 ID - Perez-Lloret2012 ER - TY - JOUR AU - Goodnick, P. J. AU - Hernandez, M. PY - 2000 DA - 2000// TI - Treatment of depression in comorbid medical illness JO - Expert Opin Pharmacother VL - 1 UR - https://doi.org/10.1517/14656566.1.7.1367 DO - 10.1517/14656566.1.7.1367 ID - Goodnick2000 ER - TY - JOUR AU - Kadoguchi, N. AU - Umeda, M. AU - Kato, H. AU - Araki, T. PY - 2008 DA - 2008// TI - Proteasome Inhibitor Does Not Enhance MPTP Neurotoxicity in Mice JO - Cell Mol Neurobiol VL - 28 UR - https://doi.org/10.1007/s10571-008-9271-4 DO - 10.1007/s10571-008-9271-4 ID - Kadoguchi2008 ER - TY - JOUR AU - Allbutt, H. N. AU - Henderson, J. M. PY - 2007 DA - 2007// TI - Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease JO - J Neurosci Methods VL - 159 UR - https://doi.org/10.1016/j.jneumeth.2006.07.006 DO - 10.1016/j.jneumeth.2006.07.006 ID - Allbutt2007 ER - TY - JOUR AU - Araki, T. AU - Mikami, T. AU - Tanji, H. AU - Matsubara, M. AU - Imai, Y. AU - Mizugaki, M. AU - Itoyama, Y. PY - 2001 DA - 2001// TI - Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse JO - Eur J Pharm Sci VL - 12 UR - https://doi.org/10.1016/S0928-0987(00)00170-6 DO - 10.1016/S0928-0987(00)00170-6 ID - Araki2001 ER - TY - JOUR AU - Kurosaki, R. AU - Muramatsu, Y. AU - Kato, H. AU - Araki, T. PY - 2004 DA - 2004// TI - Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease JO - Pharmacol Biochem Behav VL - 78 UR - https://doi.org/10.1016/j.pbb.2004.03.006 DO - 10.1016/j.pbb.2004.03.006 ID - Kurosaki2004 ER - TY - JOUR AU - Takagi, S. AU - Hayakawa, N. AU - Kimoto, H. AU - Kato, H. AU - Araki, T. PY - 2007 DA - 2007// TI - Damage of oligodendrocytes in the striatum after MPTP neurotoxicity in mice JO - J Neural Transm VL - 114 UR - https://doi.org/10.1007/s00702-007-0790-9 DO - 10.1007/s00702-007-0790-9 ID - Takagi2007 ER -